Kiwi Wealth Investments Limited Partnership Enanta Pharmaceuticals Inc Transaction History

Kiwi Wealth Investments Limited Partnership

$126 Million
Q4 2023

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	BUY	$40.77 - $53.73 $341,652 - $450,257	8,380 New	8,380 $390 Million

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.2M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$11.7 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$11 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$10.2 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$8.28 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$6.1 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $115M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kiwi Wealth Investments Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Kiwi Wealth Investments Limited Partnership with notifications on news.

Account